45
Participants
Start Date
August 23, 2021
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2026
Floxuridine
A laparotomy will be performed and a catheter placed in the hepatic artery Connected to a subcutaneous pump. This pump will be percutaneously filled with Floxuridine 6 times in 2 weeks cycles, alternating with heparin-solution.
Liver Transplantation
Patients randomized to this arm will be given 2nd line chemotherapy (regimen given at the discression of the treating oncologist) followed by liver-Tx
Oslo University Hospital, Oslo
Oslo University Hospital
OTHER